| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EFTR | Stock Option (right to buy) | Award | $0 | +40K | $0.00 | 40K | Oct 6, 2021 | Common Stock | 40K | $11.36 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | The shares subject to the option (the "Option") will vest in substantially equal monthly installments over three years, commencing on August 25, 2021, subject to the Reporting Person's continued service with the Issuer through each vesting date. |
| F2 | The Reporting Person is a member of the investment committee of Abingworth Bioventures VI, LP ("ABV VI") which approves investment and voting decisions by majority vote. Abingworth LLP provides advisory services to ABV VI and exercises investment and dispositive power over the securities held by ABV VI. Under an agreement between the Reporting Person and Abingworth LLP, the Reporting Person is deemed to hold the Option and any shares of common stock issuable upon exercise of the Option, for the benefit of ABV VI, and must exercise the Option solely upon the direction of Abingworth LLP. |
| F3 | ABV VI may be deemed the indirect beneficial owner of the Option, and the Reporting Person may be deemed the indirect beneficial owner of the Option through his indirect interest in ABV VI. The Reporting Person disclaims beneficial ownership of the Option except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person, Abingworth LLP, ABV VI or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
This Form 4 is being filed to describe the nature of the Reporting Person's form of ownership as reported in the Form 4 filed on October 8, 2021.